Akira Kondo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Akira Kondo has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Masato Maekawa
Department of Laboratory Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan
3 shared publications Takashi Kanno
Department of Laboratory Medicine, Hamamatsu University School of Medicine
3 shared publicationsKazunori Saito
Diagnostics Research Laboratories, Daiichi Pure Chemicals Co
2 shared publicationsMitsuhisa Manabe
Diagnostics Research Laboratories, Daiichi Pure Chemicals Co
2 shared publicationsJiangzhen Li
Department of Laboratory Medicine, Hamamatsu University School of Medicine
1 shared publicationMasaru Asahara
Testing Department A Laboratory, Mitsubishi Kagaku Bioclinical Laboratories, Inc
1 shared publication
Latest Publications
- 1 January 2003
- Published by Japan Atherosclerosis Society in Journal of Atherosclerosis and Thrombosis
- Vol. 10 (2) , 72-78
Relationship between High-density Lipoprotein-cholesterol and Malondialdehyde-modified Low-density Lipoprotein Concentrations
Several reports have suggested that HDL has anti-oxidative actions. We investigated the relationship between HDL-cholesterol (HDL-C) and malondialdehyde-modified LDL (MDA-LDL) concentrations using enzyme linked immunosolvent assay. We divided our study subjects into four groups on the basis of concentrations of triglyceride (TG) and HDL-C by the following lipid profiles: serum TG < or = 1.69 mmol/L and HDL-C > or = 1.16 mmol/L (control group, n = 26); TG >1.69 and HDL-C < or = 1.16 (high TG group, n = 22); TG >1.69 and HDL-C < or = 0.91 (high TG & low HDL group, n = 67); TG < or = 1.69 and HDL-C < or = 0.91 (low HDL group, n = 21). MDA-LDL concentrations, MDA-LDL/apolipoprotein B (apo B) ratio, and LDL size were different between subjects in high TG & low HDL and control groups. MDA-LDL concentrations in both high TG and low HDL groups did not differ significantly from those in the control. However, MDA-LDL/apo B ratio in low HDL group was significantly higher than that in the control (P < 0.05). The MDA-LDL/apo B ratio reflects the extent of MDA modification of apo B in LDL. Therefore, our data suggest that as HDL-C concentrations fall, the extent of MDA modification per one LDL particle increases. Moreover, accompanied by high TG concentration, LDL size in subjects with lower HDL-C concentrations became smaller.
- 1 January 2003
- Published by Japan Atherosclerosis Society in Journal of Atherosclerosis and Thrombosis
- Vol. 10 (2) , 72-78
Relationship between High-density Lipoprotein-cholesterol and Malondialdehyde-modified Low-density Lipoprotein Concentrations
Several reports have suggested that HDL has anti-oxidative actions. We investigated the relationship between HDL-cholesterol (HDL-C) and malondialdehyde-modified LDL (MDA-LDL) concentrations using enzyme linked immunosolvent assay. We divided our study subjects into four groups on the basis of concentrations of triglyceride (TG) and HDL-C by the following lipid profiles: serum TG < or = 1.69 mmol/L and HDL-C > or = 1.16 mmol/L (control group, n = 26); TG >1.69 and HDL-C < or = 1.16 (high TG group, n = 22); TG >1.69 and HDL-C < or = 0.91 (high TG & low HDL group, n = 67); TG < or = 1.69 and HDL-C < or = 0.91 (low HDL group, n = 21). MDA-LDL concentrations, MDA-LDL/apolipoprotein B (apo B) ratio, and LDL size were different between subjects in high TG & low HDL and control groups. MDA-LDL concentrations in both high TG and low HDL groups did not differ significantly from those in the control. However, MDA-LDL/apo B ratio in low HDL group was significantly higher than that in the control (P < 0.05). The MDA-LDL/apo B ratio reflects the extent of MDA modification of apo B in LDL. Therefore, our data suggest that as HDL-C concentrations fall, the extent of MDA modification per one LDL particle increases. Moreover, accompanied by high TG concentration, LDL size in subjects with lower HDL-C concentrations became smaller.
- 1 January 2002
- Published by Japan Atherosclerosis Society in Journal of Atherosclerosis and Thrombosis
- Vol. 9 (6) , 280-287
Insulin Treatment Prevents LDL from Accelerated Oxidation in Patients with Diabetes
In a study population, we compared the level of malondialdehyde-modified LDL (MDA-LDL) with the concentrations of lipid parameters in serum and found a strong correlation between MDA-LDL and apolipoprotein B (apo B) concentrations. Their interrelations had a turning point at an apo B concentration of 1,150 mg/l. In diabetic patients, the ratio of MDA-LDL/apo B increased at apo B concentrations above 1,150 mg/l. This ratio represents the extent of modification of apo B by MDA. In the control subjects, this ratio remained stable. When we divided the patients into medication groups (statins and insulin), we found that the 1,150 mg/l threshold disappeared. At apo B concentrations above 1,150 mg/l, the ratio of MDA-LDL/apo B in the statin group was as high as that in the non-drug group. In the insulin group, the means of MDA-LDL/apo B in all ranges of apo B levels decreased to an extent statistically indistinguishable from those of the control group. In conclusion, insulin therapy represses LDL oxidation even at apo B concentrations > 1,150 mg/l and should be noted for its anti-oxidation properties.
- 1 January 2002
- Published by Japan Atherosclerosis Society in Journal of Atherosclerosis and Thrombosis
- Vol. 9 (6) , 280-287
Insulin Treatment Prevents LDL from Accelerated Oxidation in Patients with Diabetes
In a study population, we compared the level of malondialdehyde-modified LDL (MDA-LDL) with the concentrations of lipid parameters in serum and found a strong correlation between MDA-LDL and apolipoprotein B (apo B) concentrations. Their interrelations had a turning point at an apo B concentration of 1,150 mg/l. In diabetic patients, the ratio of MDA-LDL/apo B increased at apo B concentrations above 1,150 mg/l. This ratio represents the extent of modification of apo B by MDA. In the control subjects, this ratio remained stable. When we divided the patients into medication groups (statins and insulin), we found that the 1,150 mg/l threshold disappeared. At apo B concentrations above 1,150 mg/l, the ratio of MDA-LDL/apo B in the statin group was as high as that in the non-drug group. In the insulin group, the means of MDA-LDL/apo B in all ranges of apo B levels decreased to an extent statistically indistinguishable from those of the control group. In conclusion, insulin therapy represses LDL oxidation even at apo B concentrations > 1,150 mg/l and should be noted for its anti-oxidation properties.
- Open Access
- 1 January 2001
- Published by Japanese Electrophoresis Society in SEIBUTSU BUTSURI KAGAKU
- Vol. 45 (1) , 65-68
Cholesteryl ester transfer protein deficiency is correlated with thyroid disease.
We investigated whether cholesteryl ester transfer protein (CETP) deficiency is a risk factor for atherosclerosis or other disease. Ninety-seven individuals with increased levels of high density lipoprotein-cholesterol (HDL-C) (≧85mg/dl) were selected. CETP deficiency was assessed in all 97 subjects by polymerase chain reaction (PCR) and either single stranded conformation polymorphism (SSCP) or restriction fragment length polymorphism (RFLP). Of the 97 subjects, 7 (7%) were heterozygous for the intron 14 splicing defect, which decreases CETP activity, and 9 (9%) were heterozygous for D442G missense mutation, which has no effect on CETP activity. One patient was found to be a compound heterozygote for the intron 14 and D442G mutations. These mutations were found in only 3 atherosclerotic patients; 2 carried the D442G mutation, and 1 had the intron 14 mutation. Although CETP activity was not associated with atherosclerosis, we discovered a novel relation between CETP gene mutations and thyroid gland disorders. Specifically, 5 of 7 subjects with CETP gene intron 14 mutation had thyroid disease. Regarding the D442G mutation, there was no difference between subjects with and without thyroid disease. It is possible that CETP activity affects thyroid function
- 1 January 2001
- Published by Japanese Electrophoresis Society in SEIBUTSU BUTSURI KAGAKU
- Vol. 45 (1) , 65-68
Open AccessCholesteryl ester transfer protein deficiency is correlated with thyroid disease.
We investigated whether cholesteryl ester transfer protein (CETP) deficiency is a risk factor for atherosclerosis or other disease. Ninety-seven individuals with increased levels of high density lipoprotein-cholesterol (HDL-C) (≧85mg/dl) were selected. CETP deficiency was assessed in all 97 subjects by polymerase chain reaction (PCR) and either single stranded conformation polymorphism (SSCP) or restriction fragment length polymorphism (RFLP). Of the 97 subjects, 7 (7%) were heterozygous for the intron 14 splicing defect, which decreases CETP activity, and 9 (9%) were heterozygous for D442G missense mutation, which has no effect on CETP activity. One patient was found to be a compound heterozygote for the intron 14 and D442G mutations. These mutations were found in only 3 atherosclerotic patients; 2 carried the D442G mutation, and 1 had the intron 14 mutation. Although CETP activity was not associated with atherosclerosis, we discovered a novel relation between CETP gene mutations and thyroid gland disorders. Specifically, 5 of 7 subjects with CETP gene intron 14 mutation had thyroid disease. Regarding the D442G mutation, there was no difference between subjects with and without thyroid disease. It is possible that CETP activity affects thyroid function
- 1 January 2000
- Published by Japanese Electrophoresis Society in SEIBUTSU BUTSURI KAGAKU
- Vol. 44 (4) , 303-307
Study of LDL by polyacrylamide gradient gel electrophoresis.
We examinied the differentiation of lipoprotein in human serum using polyacrylamide gradient gel (PAGG) electrophoresis to analyze the lipid components and to quantify the small, dense LDL. Electrophoretic patterns were classified into three types, which included two types reported by Krauss et al. and one new type containing equal same amounts of regular and small size LDL. We devised a direct staining method to stain triglyceride (TG) and cholesterol (Cho) in lipoprotein separated by the polyacrylamide gel electrophoresis and components of lipoprotein was quantitaivety analyzed with the densitogram. At the same time, the presence of apoproteins LP (a) and B in the lipoprotein was confirmed. As a result of the staining, we observed more amounts of Cho containing in the fraction of regular size LDL than small dense LDL, and more amounts of TG containing in the fraction of small dense LDL than regular size LDL. Apo B was detected in both fractions of regular size LDL and small dense LDL, but no LP (a) was detected.
- 1 January 2000
- Published by Japanese Electrophoresis Society in SEIBUTSU BUTSURI KAGAKU
- Vol. 44 (4) , 303-307
Study of LDL by polyacrylamide gradient gel electrophoresis.
We examinied the differentiation of lipoprotein in human serum using polyacrylamide gradient gel (PAGG) electrophoresis to analyze the lipid components and to quantify the small, dense LDL. Electrophoretic patterns were classified into three types, which included two types reported by Krauss et al. and one new type containing equal same amounts of regular and small size LDL. We devised a direct staining method to stain triglyceride (TG) and cholesterol (Cho) in lipoprotein separated by the polyacrylamide gel electrophoresis and components of lipoprotein was quantitaivety analyzed with the densitogram. At the same time, the presence of apoproteins LP (a) and B in the lipoprotein was confirmed. As a result of the staining, we observed more amounts of Cho containing in the fraction of regular size LDL than small dense LDL, and more amounts of TG containing in the fraction of small dense LDL than regular size LDL. Apo B was detected in both fractions of regular size LDL and small dense LDL, but no LP (a) was detected.